Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
Paolo Fiorina(Boston Children's Hospital), Reza Abdi(Brigham and Women's Hospital), Kenneth Law(Brigham and Women's Hospital), Mohamed H. Sayegh(American University of Beirut), Claudia Placidi(University of Insubria), Stefano La Rosa(University of Insubria), Jonathan Godwin(DeepMind (United Kingdom)), R. Neal Smith(Massachusetts General Hospital), Shirine Dada(Brigham and Women's Hospital), Scott J. Rodig(Brigham and Women's Hospital), Mark A. Atkinson(University of Florida), Martin K. Selig(Massachusetts General Hospital), Andrea Vergani(Brigham and Women's Hospital), Andrea Augello(University of Insubria), Mollie Jurewicz(Brigham and Women's Hospital), Carlo Capella(University of Insubria), Chaker N. Adra(Brigham and Women's Hospital)
Cited by 383
Related Papers
International evaluation of an AI system for breast cancer screening
|Nature|2020|3.1k
Type 1 diabetes
|The Lancet|2013|2.7k
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k